Glaucoma: Current Strategies for Detecting Disease Progression

This activity is supported by an unrestricted educational grant from Carl Zeiss Meditec.

Learning Objectives

At the completion of this educational activity, you will be better able to:

• Devise a plan to provide the best possible care for patients in the COVID-19 era that also optimizes practice efficiency.
• Explain the importance of high-quality screening, monitoring, and imaging devices in the care of patients with cataracts as well as those with glaucoma and retinal diseases.

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this enduring. material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sponsored by:

Evolve is an approved COPE Administrator.
This course is COPE approved for 1 hour of CE credit for optometrists.

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:

Internet Explorer 11 for Windows

Edge (recent versions; Chromium-based) for Windows

Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:

4GB+ RAM

Recommended internet speed 5Mbps+

Faculty and Disclosures

Michael Chaglasian, OD, FAAO
Associate Professor
Illinois College of Optometry
Chief of Staff
Illinois Eye Institute

Gustavo De Moraes, MD, MPH, PhD
Associate Professor of Ophthalmology
Medical Director of Clinical Trials
Vagelos College of Physicians and Surgeons
Columbia University Irving Medical Center
Edward S. Harkness Eye Institute
New York Presbyterian Hospital

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Michael Chaglasian, OD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, and Topcon. Grant/Research Support: Equinox, and Optos. Speaker’s Bureau: Allergan, Bausch + Lomb, and Novartis.

Gustavo De Moraes, MD, MPH, PhD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Belite, Carl Zeiss Meditec, Galimedex, Novartis, Perfuse Therapeutics, and Reichert. Grant/Research Support: Heidelberg Engineering, NIH, Topcon.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Carl Zeiss Meditec.